Isoprenoid pathway inhibitors for stimulating bone growth
US6376476B1 · kind B1 · utility
18Cited by
12References
23Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jan 20, 2000 |
| Grant date | Apr 23, 2002 |
| Priority date | — |
| Expiry date | Jan 20, 2020 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P19/10
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Various embodiments of statin compounds are shown to enhance the formation of bone and are thus useful in treating osteoporosis, bone fracture or deficiency, primary or secondary hyperparathyroidism, periodontal disease or defect, metastatic bone disease, osteolytic bone disease, post-plastic surgery, post-prosthetic joint surgery, and post-dental implantation.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.